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RLR-mediated antiviral innate 
immunity requires oxidative 
phosphorylation activity
Takuma Yoshizumi1, Hiromi Imamura2, Tomohiro Taku3, Takahiro Kuroki3, Atsushi 
Kawaguchi3, Kaori Ishikawa4, Kazuto Nakada4 & Takumi Koshiba1
Mitochondria act as a platform for antiviral innate immunity, and the immune system depends on 
activation of the retinoic acid-inducible gene I (RIG-I)-like receptors (RLR) signaling pathway via an 
adaptor molecule, mitochondrial antiviral signaling. We report that RLR-mediated antiviral innate 
immunity requires oxidative phosphorylation (OXPHOS) activity, a prominent physiologic function 
of mitochondria. Cells lacking mitochondrial DNA or mutant cells with respiratory defects exhibited 
severely impaired virus-induced induction of interferons and proinflammatory cytokines. Recovery of 
the OXPHOS activity in these mutants, however, re-established RLR-mediated signal transduction. 
Using in vivo approaches, we found that mice with OXPHOS defects were highly susceptible to viral 
infection and exhibited significant lung inflammation. Studies to elucidate the molecular mechanism of 
OXPHOS-coupled immune activity revealed that optic atrophy 1, a mediator of mitochondrial fusion, 
contributes to regulate the antiviral immune response. Our findings provide evidence for functional 
coordination between RLR-mediated antiviral innate immunity and the mitochondrial energy-
generating system in mammals.
Innate immunity is a ubiquitous system that widely protects organisms from infectious pathogens as a front-line 
host defense mechanism. The immune response is triggered by the recognition of broadly conserved microbial 
components, known as pathogen-associated molecular patterns, by germline-encoded pattern recognition recep-
tors of the host cells1. As an early defense system against RNA viruses in mammals, the innate immune response 
is precisely controlled by two distinct signal transduction pathways mediated by the pattern recognition recep-
tors Toll-like receptor 3 (TLR-3) and retinoic acid-inducible gene I (RIG-I)-like receptors (RLR) that respond 
to virus-derived RNAs2, 3 (i.e., pathogen-associated molecular patterns). Although the two pathways differ with 
respect to the initial activation of their downstream effectors, they converge at the point of activation of the 
transcriptional factors interferon regulatory factor 3 (IRF-3) and nuclear factor κB (NF-κB), which results in the 
rapid production of type I interferons (IFN-α and -β) and other proinflammatory cytokines to establish adaptive 
antiviral immunity4.
Mitochondria, eukaryotic cell powerhouses, are crucially involved in numerous cellular processes, including 
apoptosis5 and calcium homeostasis6. Mitochondria also have a unique role in innate immunity against RNA 
viruses7. Mitochondrial-mediated antiviral immunity depends on activation of the RLR signaling pathway, and 
mitochondrial antiviral signaling (MAVS), a downstream adaptor of RLR at the mitochondrial outer membrane 
(MOM), has a key role in the signal transduction8, 9. Upon viral infection, MAVS recruits various types of effec-
tors at the MOM, and the orchestrated “MAVS signalosome”, including the mitochondrial membrane potential 
(Δψm), is the primary unit governing antiviral innate immunity10, 11. Although the role of the MAVS signalosome 
in mitochondria with its dynamic morphologic properties12 to provide a molecular platform that facilitates sig-
nal transduction is well characterized, insight into how the organelle functions to facilitate antiviral immunity 
through the activity of oxidative phosphorylation (OXPHOS) has remained unclear.
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Results and Discussion
Cultured cells rely on mitochondrial respiratory activity. To evaluate the functional coordination 
of mitochondrial-mediated antiviral immunity and OXPHOS activity, we first sought to determine optimal cell 
culture conditions in which the cellular bioenergetics would rely on mitochondrial respiratory activity. We used 
a fluorescence resonance energy transfer (FRET)-based assay to visualize metabolized intracellular adenosine 
5′-triphosphate (ATP) at the single-cell level in human embryonic kidney 293 (HEK293) cells expressing an ATP 
probe, ATeam1.0313. The biosensor assay performed with cells cultured under our customized medium contain-
ing galactose (10 mM) as the carbon source revealed high FRET signal [based on an emission ratio of 527/475 nm 
(denoted YFP/CFP)] in individual cells [Fig. 1A, galactose panels, (−)], indicating that cells maintained adequate 
intracellular ATP levels. The intracellular ATP level, however, which affects the YFP/CFP ratio, was dramatically 
decreased (~2.5-fold) by the addition of electron transport chain (ETC) inhibitors (rotenone and antimycin A), an 
ATP synthase inhibitor (oligomycin), or a protonophore [carbonyl cyanide m-chlorophenylhydrazone (CCCP)] 
to the media [Fig. 1A, galactose panels, (+), and B], demonstrating that energy production in the cells critically 
depends on mitochondrial OXPHOS. In contrast, cells maintained in a customized medium containing glucose 
(10 mM) exhibited no significant decrease in the intracellular ATP level, even after treatment with the pharma-
cologic drugs (Fig. 1A,B). These results clearly demonstrated that the cellular bioenergetics are less dependent on 
OXPHOS activity in the presence of glucose, and that cellular ATP production predominantly relies on glycolysis.
Validation of the RLR signaling pathway under oxidative conditions. We examined RLR-mediated 
signal transduction under the galactose-containing oxidative condition. Under oxidative conditions, simi-
lar to the glucose condition, ectopic expression of MAVS in HEK293 cells potently activated both IFN-β and 
NF-κB luciferase reporters in a dose-dependent manner (Supplementary Fig. S1A). The OXPHOS-dependent 
RLR-mediated signal transduction was also confirmed by stimulating cells transfected with either a plasmid 
encoding RIG-I(1–250) (Supplementary Fig. S1B) or a synthetic analog of viral double-stranded RNA [dsRNA; 
poly(I:C)] (Supplementary Fig. S1C and D), both of which are upstream factors of MAVS3. The kinetic response 
of IRF-3 phosphorylation (a hallmark of IRF-3 activation) in cells against infection by Sendai virus (SeV), a 
negative-stranded RNA virus of the Paramyxoviridae family, in the OXPHOS-dependent condition was also 
similar to that in the glucose condition (Fig. 2A). The RIG-I-mediated activation of the IFN-β reporter in the 
OXPHOS-dependent condition was sufficiently impaired by co-expression of a hepatitis C virus serine protease 
NS3/4A (an inhibitor of the RLR signaling pathway)14, 15 [Fig. 2B, wild-type (WT)], whereas its inactive mutant 
Figure 1. Bioenergetic profiling of cells under oxidative conditions. (A) HEK293 cells stably expressing the 
ATeam1.03 were cultured in customized media containing either galactose (right) or glucose (left) at 37 °C, and 
then the indicated mitochondrial inhibitors were added to each medium. The time-course of the fluorescence 
emission ratio (YFP/CFP) was monitored to visualize cytosolic ATP levels in each living cell, and ratiometric 
pseudocolor images of cells pre- (−) or post-treated (+) with inhibitors are shown. The images were processed 
in MetaMorph (Molecular Devices), and the blue color indicates less cytoplasmic ATP. Scale bar, 20 μm. 
(B) Quantification of the YFP/CFP ratio calculated from images in (A). Number of cells (n) used for the 
quantification is shown at the top of the graph. Error bars indicate SD (Unpaired t-test; ***P < 0.001).
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Figure 2. RLR-mediated signal transduction under oxidative conditions. (A) The kinetic profile of IRF-3 
activation in oxidative or glycolytic medium-cultured HEK293 cells that were challenged with SeV (4 HA units/
mL). Each cell lysate was collected at the indicated time-points (3, 6, 9 and 12 h) and analyzed by Western 
blotting with antibodies against the specific antibody (pIRF-3; phosphorylation of Ser386). Anti-β-actin was 
used as the loading control and anti-SeV as the infection control. U.I., uninfected. (B) Oxidative medium-
cultured HEK293 cells were transfected with 50 ng of empty vector (Mock) or expression plasmid for Myc-
tagged RIG-I(1–250) (control) together with the IFN-β reporter plasmid. The two right lanes (+NS3/4A) 
indicate that 100 ng of FLAG-tagged WT or inactive (S139A) NS3/4A serine protease expression plasmids 
were also co-transfected with the RIG-I(1–250) plasmid. The immunoblot on the top represents an expression 
profile of Myc-tagged RIG-I(1–250) and FLAG-tagged NS3/4A mutants as well as the loading control of 
endogenous β-actin. Error bars indicate SD (n = 3; Unpaired t-test; **P < 0.01 and ***P < 0.001, respectively). 
(C) BRET saturation assay of MAVS oligomerization in glycolytic versus oxidative media. HEK293 cells were 
co-transfected with 5 ng NLuc-MAVS expression plasmid and increasing amounts (0–200 ng) of Venus-tagged 
MAVS plasmid along with 200 ng of WT (circles) or S139A (squares) FLAG-tagged NS3/4 A plasmids, and 
analyzed 24 h later using a BRET saturation assay. Closed and open symbols represent glycolytic and oxidative 
conditions of HEK293 cells, respectively, and inset blots show Western blots from the BRET saturation point of 
each curve by immunoblotting with the indicated antibodies. Error bars indicate SEM (n = 3). (D) Heat maps 
of microarray analysis. Total RNAs were isolated from glycolytic and oxidative cultured conditions of primary 
MEFs that were unchallenged (−) or challenged (+) with SeV (30 HA units mL−1) for 6 h, and microarray 
analysis was performed. The heat map was generated by MeV software42, and the color indicates the distance 
from the median of each row. (E) Similar to (A), except that J774A.1 macrophages were challenged with SeV (2 
HA units/mL). U.I., uninfected.
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(S139A) had no functional effect, indicating that the observed signal transduction occurred via RLR-dependent 
signaling pathway.
We next analyzed the structural features of MAVS activation accompanied by RLR-mediated signal trans-
duction, homotypic oligomerization at the MOM11, when cells were dependent on the oxidative condition. 
The interaction between ectopically expressed Venus- and NanoLuc luciferase (NLuc)-tagged MAVS with 
co-expression of the S139A mutant was successfully monitored, and a bioluminescence resonance energy trans-
fer (BRET)-based assay16 revealed a hyperbolic saturation curve characteristic of a specific interaction (Fig. 2C, 
squares). Importantly, the specificity of the observed MAVS-MAVS interaction was verified by the disappearance 
of the saturated curve when the WT NS3/4A protease was co-expressed in cells due to MAVS cleavage14 (Fig. 2C, 
circles, also see immunoblot). We further verified the antiviral immune response of primary mouse embryonic 
fibroblasts (MEFs) against SeV infection in the OXPHOS-dependent condition. Gene expression profiling of 
MEFs showing its dependence on the oxidative condition (Supplementary Fig. S2, upregulation of OXPHOS 
genes) revealed the expected induction of numerous IFN-stimulated and antiviral-signaling genes in response 
to the viral infection, similar to that observed in the glucose condition (Fig. 2D). Consistent with the aforemen-
tioned assays, we also observed that the antiviral immune response of macrophages cultured under the oxidative 
conditions was intensively upregulated upon SeV infection (Fig. 2E).
RLR-mediated antiviral innate immunity requires OXPHOS activity. Because altering the energy 
metabolism in cells through the activity of OXPHOS could accomplish the antiviral immune response, we next 
asked whether arresting OXPHOS activity would disrupt RLR-mediated signal transduction. IRF-3 phospho-
rylation in cells responding to SeV infection was completely suppressed by the addition of ETC inhibitors to the 
medium under oxidative conditions (Figs 3A and S3). The functionality of the cells treated with the pharmaco-
logic drugs under these conditions, however, was unaffected when the cells were either stimulated with extracel-
lular poly(I:C) (Supplementary Fig. S4A) or infected with a double-stranded DNA virus, Herpes simplex virus 1 
(HSV-1) (Supplementary Fig. S4B), which activates the TLR-3 or cGAS/STING cytosolic DNA sensing pathways, 
respectively. Influenza A virus (IAV; PR8 strain), an RNA virus of the Orthomyxoviridae family, encodes the viral 
protein PB1-F2 that translocates into mitochondria and induces mitochondrial depolarization17–20. Using the 
viral strain, we observed severe PB1-F2–induced inhibition of RLR signaling in cells that depended on OXPHOS 
(Fig. 3B, WT); the inhibitory effect was attenuated, however, when we used a recombinant virus with genetic abla-
tion of the PB1-F2 gene (ΔF2)21. These observations suggest that the severity of the mitochondrial dysfunction 
correlates with the severity of the defect in the RLR-induced antiviral response.
We next used a genetic approach to examine whether mitochondrial DNA (mtDNA), which is essential for 
mitochondrial OXPHOS activity22, modulates RLR-mediated signal transduction. Mouse fibrosarcoma B82 cells 
devoid of mtDNA (ρ0 B82)23 (Supplementary Fig. S5A) produced less IFN-β and IL-6 against SeV infection, 
although the immune response was fully rescued in a cell cybrid harboring WT mtDNA (Fig. 3C), despite the 
fact that both cell types had adequate energy due to the use of a high glucose medium (25 mM) with pyruvate and 
uridine (Supplementary Fig. S5B) or the same infection level (Supplementary Fig. S5C). Conversely, ρ0 B82 cells 
had substantial antiviral responses against HSV-1 infection (Fig. 3D), consistent with a previous observation24. To 
confirm that these observations were not due to specific characteristics of the cell type we used, we performed the 
same experiment in HeLa cells lacking mtDNA25 (ρ0 HeLa), and found that ρ0 HeLa cells also exhibited defective 
antiviral innate immune responses against SeV infection (Supplementary Fig. S5D and E). In addition, transient 
depletion of mtDNA in macrophages (mtDNA-less J774A.1) treated with rhodamine 6G exhibited an impaired 
immune response against SeV infection (Fig. 3E). Taken together, these findings indicated that RLR-mediated 
signal transduction requires OXPHOS activity to execute antiviral immune responses.
Pathogenic mtDNA mutations cause defects in antiviral innate immunity. The importance of 
mtDNA in the regulation of RLR-mediated signal transduction prompted us to explore the phenotypic effects of 
pathogenic mtDNA mutations on antiviral immunity. We used human osteosarcoma cybrid 143B cells harboring 
homoplasmic pathogenic mtDNA mutations: the ND1 cybrid26 (complex I dysfunction), which is associated 
with Leber hereditary optic neuropathy, carrying a missense mutation at 3460/ND1 (Supplementary Fig. S6A); 
and the COX cybrid27 (missing complex IV), which is associated with mitochondrial encephalopathy, carrying a 
stop codon mutation at 6930/COXI (Supplementary Fig. S6B), both of which exhibit severe respiratory defects. 
As described, ρ0 cells from 143B cell lines also exhibited an impaired immune response against SeV infection 
(Fig. 4A,B). Remarkably, activation of the RLR-mediated antiviral signaling in the mutant cells (ND1 and COX) 
was severely disrupted (Fig. 4A,B) despite the indistinguishable MAVS pattern and energy supply (Supplementary 
Fig. S7A, B and C). Consistent with these results, both pathogenic mutants were more susceptible to viral infec-
tion (recombinant IAV-expressing GFP)28 than WT cells (Fig. 4C), due to defective mitochondrial-mediated 
immunity. Most importantly, the immunodeficiency observed in the ND1 cybrid, but not in the COX cybrid, 
was significantly recovered by the addition of succinate, a complex II substrate, to the media, suggesting that 
OXPHOS activity in ND1 mutant cells was driven by the substrate through complex II, which consequently 
restored its phenotype (Fig. 4D). Together, these results indicated that cells with defective OXPHOS activity due 
to mtDNA mutations have severely impaired RLR-mediated antiviral signaling.
Trans-mitochondrial mice (Mito-miceΔ) are susceptible to IAV infection. To evaluate whether our 
in vitro observations were physiologically relevant, we investigated the relationship between OXPHOS and antivi-
ral innate immunity in vivo. We used 28-week-old trans-mitochondrial mice carrying mtDNA with a large-scale 
deletion (Mito-miceΔ)29 and challenged the mice with the IAV PR8 strain. Mito-miceΔ in a resting state had 
high blood lactate levels (7.2 ± 2 mmol/L) relative to those in WT mice (3.2 ± 0.4 mmol/L), showing lactic aci-
dosis in the mutant mice. Although the mortality of Mito-miceΔ (n = 7) infected with IAV was not much worse 
www.nature.com/scientificreports/
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Figure 3. OXPHOS activity couples with the RLR pathway to execute antiviral signal transduction. (A) 
HEK293 cells cultured in glycolytic or oxidative media were infected with SeV (4 HAU/mL) for 2.5 h, and the 
infected cells were further incubated with the indicated mitochondrial inhibitors for 2.5 h (total 5 h infection). 
The activation of endogenous IRF-3 was analyzed by Western blotting with antibodies against the specific 
antibody (pIRF-3; Ser386). Anti-β-actin was used as the loading control. U.I., uninfected. (B) Comparison of 
the IRF-3 activation between cells infected with recombinant influenza A/PR8 viruses (WT versus ΔF2, each 
used 2 HAU/mL) cultured under oxidative conditions. The ΔF2 strain is a mutant strain with genetic removal 
of the PB1-F2 gene from the viral genome21. The graph on the right shows the quantification of pIRF-3 bands 
analyzed by densitometry. Error bars indicate SD (n = 3; Unpaired t-test; *P < 0.05). (C,D) The B82 WT 
cybrids and ρ0 cells were infected with (C) SeV (4 HAU/mL) for 18 h or (D) HSV-1 (1 × 105 PFU) for 24 h, and 
the cell-free supernatants were analyzed by ELISA to measure the secreted amounts of IFN-β (left panel) and 
IL-6 (right panel), respectively. Error bars indicate SD (n = 3; Unpaired t-test; **P < 0.01 and ***P < 0.001, 
respectively). U.I., uninfected. N.D., not detected. (E) Similar to (C), except that the mtDNA-less J774A.1 and its 
parental macrophages were infected with SeV (2 HA units/mL). Inset panel: relative mtDNA copy number was 
confirmed by qPCR. In (C–E), cells were maintained in ρ0 medium.
www.nature.com/scientificreports/
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than that of WT mice (n = 9) (Supplementary Fig. S8A), the Mito-miceΔ exhibited significant weight loss during 
the monitoring period (Fig. 5A; 17% of Mito-miceΔ versus 4% of WT on day 7). Given the higher pathogenicity 
in Mito-miceΔ following IAV-infection, we examined the physiologic effects of the infection on the lung tissue. 
In the lungs of WT mice infected with IAV, mild hyperemia and perivascular inflammatory cells infiltration 
Figure 4. Defects in mtDNA cause malfunction in antiviral innate immunity. (A,B) The 143B cybrids and ρ0 
cells were infected with SeV (5 HAU/mL) for 18 h, and (A) activation of both IRF-3 and IκBα was analyzed by 
Western blotting with antibodies against its specific phosphorylated-detection antibodies (Ser386 for IRF-3 and 
Ser32/36 for IκBα) or (B) the cell-free supernatants were analyzed by ELISA to measure the secreted amounts 
of IFN-β (top panel) and IL-6 (bottom panel). U.I., uninfected. Error bars indicate SD (n = 3; Unpaired t-test; 
***P < 0.001). (C) Fluorescence microscopy of 143B cybrid cells infected with IAV-GFP (0.6 HAU/mL) for 24 h. 
In (A–C), cells were maintained in ρ0 medium. (D) Similar to (B), except that succinate (suc), the complex II 
substrate with ADP, was added to the oxidative medium as indicated. Error bars indicate SD (n = 3; Unpaired t-
test; ***P < 0.001; N.D., not detected; N.S., not significant).
www.nature.com/scientificreports/
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around the bronchus were minimally observed, but few alveoli were injured by the infection (Fig. 5B, left panels). 
On the other hand, Mito-miceΔ infected with the virus had significant inflammation in whole lung tissues with 
desquamation of the bronchial epithelium (Fig. 5B, right panels, see arrowheads) and alveolar pneumocyte hyper-
plasia. Notably, virus-induced expression of endogenous IFN-β was impaired in the lungs of the Mito-miceΔ 
(Supplementary Fig. S8B), explaining the histopathologic observation of enhanced pathogenicity. We thus con-
cluded that defective OXPHOS enhances the susceptibility to IAV infection in vivo, emphasizing the importance 
of mitochondrial respiration for modulating innate immunity.
OPA1-mediated execution of antiviral innate immunity. To elucidate the molecular basis of 
OXPHOS activity coupled with the RLR signaling pathway, we speculated that optic atrophy 1 (OPA1), a medi-
ator of mitochondrial fusion30, has a role in antiviral innate immunity12 because of its stabilizing effects on 
mtDNA31 and the cristae structure32, 33, both of which contribute to regulating mitochondrial respiration. As 
reported previously, we observed that OPA1−/− cells contained less mtDNA (Fig. 6A), completely lacked mito-
chondrial fusion (Supplementary Fig. S9A), and had a disrupted cristae morphology (Supplementary Fig. S9B). 
These phenotypic defects were restored when a WT OPA1 isoform gene (L-OPA1; variant 1), but not an inactive 
mutant K301A or short isoform (S-OPA1), was re-introduced into null cells. Strikingly, although the OPA1−/− 
cells exhibited severely impaired SeV-induced production of IFN-β and IL-6 (Fig. 6B), the immune responses 
were substantially restored by recovery of the mtDNA level in rescued cells [Figs 6A,C and S9C; V1(WT)]. Given 
Figure 5. OXPHOS-defective mice are highly susceptible to viral-infection. (A) Mito-miceΔ (n = 7) or WT 
mice (n = 9) were challenged with IAV (1 × 103 PFU) and mouse weight loss was monitored for 14 days. In the 
graph, the percentage change from the initial weight of the mice is shown. Error bars indicate SEM [Dunnett’s 
test; **P < 0.01 and ****P < 0.0001 (versus day 0), respectively)]. #Dunnett’s test could not be applied because 
dead mice appeared from day 9. (B) In a separate experiment, the lungs were obtained from each infected 
mouse on day 8 post-infection, sectioned, and analyzed for histopathology following staining with hematoxylin 
and eosin. Enlarged boxes are depicted in lower images (400× magnification). Labels A and B in the images 
indicate alveoli and bronchus, respectively, and arrowheads indicate desquamation of the bronchial epithelium. 
Scale bars, 100 μm (top) and 50 μm (bottom), respectively.
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that OPA1 is important for mtDNA stability and the antiviral immune response, we used histochemical staining 
for cytochrome c oxidase (complex IV) activity to directly assess the OPA1 function involved in mitochondrial 
respiration. As expected, the COX staining pattern of the V1(WT)-rescued OPA1−/− cells showed full recovery of 
the respiration defect, whereas K301A and S-OPA1 failed to rescue the COX activities (Fig. 6D). Taken together, 
these results indicate that functional actions of OPA1 are linked to the improvement of OXPHOS activity and the 
induction of mitochondrial-mediated antiviral innate immunity.
The findings of the present study using both in vitro and in vivo approaches provided new insight into how 
mitochondria facilitate antiviral immunity through OXPHOS activity. Mitochondria are believed to have evolved 
from organisms such as α-proteobacterium, and the discovery of their role in host-cell defense was unexpected. 
It is not surprising, however, that cells gaining respiratory function through a symbion could greatly advance not 
only through enhanced energy production, but also through safeguarded host defense against other infectious 
pathogens, especially in vertebrates.
Figure 6. OPA1 contributes to mitochondrial-mediated antiviral signaling through stabilizing mtDNA. (A) 
Analysis of mtDNA copy number per nuclear DNA in WT and mutant MEFs. Restoration of mtDNA in OPA1 
null cells was measured in mutant cells infected with a retrovirus-expressing variant 1 WT OPA1 [V1(WT)], 
its K301A mutant [V1(K301A)], and short isoform OPA1 (S-OPA1). Error bars indicate SEM (n = 3; Unpaired 
t-test; **P < 0.01). (B) SeV-induced antiviral innate immune response in OPA1-null MEFs. The WT and 
OPA1-null MEFs were either uninfected (U.I.) or infected with SeV (4 HAU/mL) for 18 h, and the cell-free 
supernatants were analyzed by ELISA to measure the secreted amounts of IFN-β (left panel) and IL-6 (right 
panel). Error bars indicate SD (n = 3; Unpaired t-test; **P < 0.01 and ***P < 0.001, respectively). N.D., not 
detected. (C) Similar to (B), except that the immune response in mutant OPA1 MEFs was monitored. Error bars 
indicate SD (n = 3; Unpaired t-test; ***P < 0.001). (D) Cytochemical analysis of COX activity. Cells expressing 
COX activity were indicated by a brown color. Scale bar, 20 μm.
www.nature.com/scientificreports/
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Materials and Methods
Reagents. CCCP, rotenone, oligomycin, and antimycin A were purchased from Sigma-Aldrich (St. Louis, 
MO). Cytochrome c from horse heart was supplied by Nacalai Tesque Inc. (Kyoto, Japan) and 3,3′-diaminobenzi-
dine was purchased from Tokyo Chemical Industry Co. Ltd. (Tokyo, Japan). Furimazine was supplied by Promega 
(Madison, WI) and poly(I:C) was purchased from InvivoGen (San Diego, CA). Enzyme-linked immunosorbent 
assay (ELISA) kits for human and mouse IFN-β were supplied by Kamakura Techno-Science Inc. (Kanagawa, 
Japan) and PBL Assay Science (Piscataway, NJ), respectively. All other reagents were of biochemical research 
grade.
Antibodies. A polyclonal antibody against IRF-3 (FL-425; 1:2000) and monoclonal antibody against β-actin 
(C4; 1:4000) were purchased from Santa Cruz Biotechnology (Dallas, TX), and the rabbit monoclonal anti-
body against phosphorylated IRF-3 (pIRF-3) Ser386 (EPR2346; 1:2000) and polyclonal antibody against MAVS 
(ab25084; 1:1000) were from Abcam (Cambridge, MA). Monoclonal antibodies against Myc (9E10; 1;1000) and 
FLAG (M2; 1:1000) were obtained from Covance (Princeton, NJ) and Sigma-Aldrich, respectively. Monoclonal 
antibodies against phosphorylated IκBα (pIκBα) Ser32/36 (5A5; 1:1000), phosphorylated NF-κB p65 (pNF-κB 
p65) Ser536 (93H1; 1:2000) and NF-κB p65 (D14E12; 1:3000) were supplied by Cell Signaling Technology 
(Danvers, MA), and the monoclonal antibody against OPA1 (1:2000) was from BD Biosciences (San Jose, CA). 
The anti-human and anti-mouse IL-6 antibodies used for ELISA were obtained from eBioscience, and a poly-
clonal antibody against SeV (PD029; 1:1000) was purchased from MBL (Nagoya, Japan). Monoclonal antibodies 
against mtCO1 (1D6E1A8; 1:1000) and mitochondrial heat shock protein 70 (mtHsp70; 1:2000) were purchased 
from Molecular Probes/Invitrogen (Carlsbad, CA) and Affinity BioReagents (Golden, CO), respectively. The 
Alexa Fluor 488–conjugated polyclonal antibody against rabbit immunoglobulin G (IgG) and Alexa Fluor 568–
conjugated polyclonal antibody against rabbit IgG (1:500) were obtained from Molecular Probes-Invitrogen, 
and the Cy3-conjugated sheep anti-mouse IgG (1:1000) monoclonal antibody was purchased from Jackson 
ImmunoResearch Laboratories (West Grove, PA). A monoclonal antibody against PB1-F2 (A/PR8 strain; 1:10) 
was a kind gift from Viktor Wixler (Münster University Hospital Medical School).
Plasmids. Plasmids encoding human MAVS variants, hRIG-I(1–250), NS3/4A variants, and the ATeam1.03 
were described previously13, 16, 20, 34. Plasmid encoding rat OPA1 was a gift from Naotada Ishihara (Kurume 
University, Japan). To generate the retroviral expression constructs, each cDNA was recloned into the retroviral 
vector pMXs-Puro (Cell Biolabs, San Diego, CA). The retroviral expression vectors were then transfected into the 
platinum packaging cell lines (Cell Biolabs), and the retroviral supernatant was harvested 48 h post-transfection 
and used to infect cells.
Cell lines and viruses. HEK293, MEF, and J774A.1 cells were maintained in Dulbecco’s modified Eagle 
medium (high glucose; 4,500 mg/L; GIBCO BRL) supplemented with 1% GlutaMAX, penicillin (100 U/
mL)-streptomycin (100 μg/mL), and 10% fetal bovine serum at 5% CO2 and 37 °C. The ρ0 cells (lacking mtDNA) 
from HeLa, B82 (mouse fibrosarcoma), and 143B (human osteosarcoma) and its WT or mutant mtDNA cybrids 
were similarly maintained, except with the addition of sodium pyruvate (110 mg/L) and uridine (50 μg/mL; 
ρ0 medium). The mtDNA-less J774A.1 macrophages were pretreated with rhodamine 6 G (0.06 μg/mL in ρ0 
medium) for 48 h to transiently eliminate endogenous mtDNA. For glucose-free culture experiments, glycolytic 
(glucose) and oxidative (galactose) media were customized according to previously published protocols35 with 
slight modifications; the glycolytic medium was distinct from the high glucose medium used to maintain the 
cultures. The customized medium was based on glucose and glutamine-free Dulbecco’s modified Eagle medium 
(GIBCO; A14430–01) externally supplemented with 10% dialyzed fetal bovine serum (GIBCO; 26400–044), 
2% GlutaMAX, penicillin (100 U/mL)-streptomycin (100 μg/mL), and either 10 mM glucose (glycolytic) or 
10 mM galactose (oxidative), respectively. Sendai virus Cantell strain was purchased from the American Type 
Culture Collection, and the recombinant influenza viruses A/PR8 (ΔF2)21 and IAV-GFP28 were a generous gift 
from Jonathan A. McCullers (St. Jude Children’s Research Hospital) and Adolfo García-Sastre (Icahn School of 
Medicine at Mount Sinai), respectively.
Viral infection in vivo. Twenty eight-week-old C57BL/6 mice were anesthetized with isoflurane and inocu-
lated intranasally with 50 μL containing 1 × 103 PFU of A/PR8. One group of mice was mock-infected with sterile 
phosphate buffered saline (PBS) as a control. Mice were observed daily for weight loss and mortality for 14 days. 
For histopathologic analysis, dissected lung tissues were fixed in 3.5% formaldehyde and paraffin-embedded. 
Tissues were sliced into 6-μm-thick paraffin sections and stained with hematoxylin and eosin. To determine the 
level of IFN-β mRNA, mice were euthanized 4 days post-infection, and the total RNAs were purified from 30 mg 
of lung tissue homogenate using an RNeasy Kit (Qiagen). All animal experiments were carried out in a humane 
manner after receiving approval from the Institutional Animal Care and Use Committee of the University 
of Tsukuba, and in accordance with the regulation for Animal Experiments in University of Tsukuba and 
Fundamental Guideline for Proper Conduct of Animal Experiment and Related Activities in Academic Research 
Institutions under the jurisdiction of the Ministry of Education, Culture, Sports, Science, and Technology.
Luciferase assays. HEK293 cells were plated in 24-well plates (2.5 × 105 cells per well) in the customized 
media. The following day, the cells were co-transfected with 100 ng luciferase reporter plasmid (p125luc or 
pELAM), 2.5 ng Renilla luciferase internal control vector phRL-TK (Promega), and each of the indicated expres-
sion plasmids with Lipofectamine 2000 reagent (Invitrogen). Empty vector [pcDNA3.1(−)] was used to main-
tain equivalent amounts of DNA in each well. Cells were harvested 24 h after transfection and analyzed by a 
dual-luciferase reporter assay on the GloMax 20/20n luminometer (Promega). Each experiment was repeated at 
least three times.
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BRET assay. All BRET saturation assays were performed as previously described16 with slight modifications. 
In brief, HEK293 cells (5 × 105 cells per well) cultured under customized media were co-transfected with a con-
stant amount (5 ng) of NLuc-tagged MAVS plasmid and increasing amounts of Venus-tagged MAVS constructs 
using Lipofectamine 2000 reagent. Empty vector [pcDNA3.1(−)] was used to maintain equivalent amounts of 
DNA in each well. The cells were harvested at 21 h post-transfection and transferred to each well of white 96-well 
microplates. NLuc substrate (furimazine; 5 μM) was added, and the plates were analyzed via a BRET saturation 
assay using a Flexstation 3 Microplate Reader (Molecular Devices, Sunnyvale, CA) at 37 °C.
ELISA. Measurements of species-specific IFN-β and IL-6 production were performed as described previ-
ously20, 36.
Microarray analysis. Total RNA was isolated from each cultured condition of primary MEFs using TRIzol 
Reagent (Invitrogen) and purified using SV Total RNA Isolation System (Promega) according to the manufac-
turer’s protocol. RNA samples were quantified using an ND-1000 spectrophotometer (NanoDrop Technologies, 
Wilmington, DE) and the quality was confirmed with an Experion System (Bio-Rad Laboratories, Hercules, CA). 
The cRNA was amplified, labeled (Low Input Quick Amp Labeling Kit), and hybridized to the SurePrint G3 
Mouse Gene Expression 8 × 60 K microarray according to the manufacturer’s instructions (Agilent Technologies, 
Santa Clara, CA). All hybridized microarray slides were scanned by an Agilent scanner (Agilent Technologies). 
Relative hybridization intensities and background hybridization values were calculated using Agilent Feature 
Extraction Software (9.5.1.1). Raw signal intensities and flags for each probe were calculated from the hybridi-
zation intensities (gProcessedSignal), and spot information (gIsSaturated, etc.), according to the procedures rec-
ommended by Agilent. The raw signal intensities of four samples were normalized by a quantile algorithm with 
the ‘preprocessCore’ library package37 of the Bioconductor software38. To identify upregulated or downregulated 
genes, we calculated the Z-scores39 and ratios (non-log scaled fold-change) from the normalized signal intensities 
of each probe to compare between control and experiment samples, and established criteria for regulated genes: 
Z-score ≥2.0 and ratio ≥1.5-fold for upregulated genes, and Z-score ≤−2.0 and ratio ≤0.66 for downregulated 
genes, respectively.
Visualization of cytoplasmic ATP in living cells. Imaging of cytoplasmic ATP levels in living cells was 
performed as previously described13, 40. Briefly, cells expressing ATeam1.03 were plated on collagen-coated 35-mm 
glass-bottom dishes (MatTek, Ashland, MA). The following day, the cells were washed once with the customized 
media and the cells were subjected to ATP imaging. Observations of cells that were maintained at 5% CO2 and 
37 °C using a stage-top incubator (Tokai Hit, Shizuoka, Japan) were performed using a Nikon ECLIPSE Ti-E 
microscope with an oil-immersion type CFI Plan Apo VC 60x lens (Nikon Instruments Inc, Tokyo, Japan). The fil-
ters, 438/24-nm BrightLine single-band bandpass filter (FF01–438/24–25), 458-nm edge BrightLine single-edge 
dichroic mirror (FF458-Di02), and two emission filters (FF01–483/32 and FF01–542/27) used for dual-emission 
ratio imaging of ATeam1.03 were obtained from Semrock Inc. (Rochester, NY). Fluorescence emission from the 
ATeam1.03 was imaged by altering the emission filters with a filter changer and a scientific CMOS camera (Zyla 
4.2, Andor Technology), and the imaging analysis was performed using MetaMorph (Molecular Devices). The 
YFP/CFP emission ratio was calculated by dividing the YFP intensity by the CFP intensity of each cell.
Confocal microscopy. Cells were plated on coverslips in 12-well plates (1.5 × 105 cells per well). The follow-
ing day, cells were fixed with 4% paraformaldehyde for 10 min, permeabilized with 0.2% Triton X-100 in PBS (pH 
7.4), and blocked with 5% bovine calf serum. Endogenous MAVS was detected with the polyclonal primary and 
AlexaFluor488 secondary antibodies, and mitochondria were stained with anti-mtHsp70 primary antibody fol-
lowed by the Cy3-conjugated secondary antibody. Cells were imaged with the C2+ confocal microscope (Nikon 
Instruments Inc).
Electron microscopy analysis. For electron microscopy, cells were fixed in 100 mM cacodylate buffer (pH 
7.4) containing 2% paraformaldehyde and 2% glutaraldehyde (GA) for 1 h, washed and fixed again with 100 mM 
cacodylate buffer containing 2% GA overnight at 4 °C. After fixation, the cells were washed four times with 
100 mM cacodylate buffer for 20 min each, and postfixed with 2% osmium tetroxide (OsO4) in cacodylate buffer 
at 4 °C for 1 h. Cells were then dehydrated in a graded series of ethanol (50%, 70%, 90%, and 100%), embedded in 
resin (Quetol 812, Nisshin EM Co., Japan), and polymerized at 60 °C for 48 h. The polymerized resins were cut in 
ultra-thin sections at 70 nm with an LEICA UTC ultramicrotome, mounted on copper grids, and stained with 2% 
uranyl acetate and lead solution (Sigma-Aldrich). Images were collected with a transmission electron microscope 
(JEM-1400Plus; JEOL Ltd, Japan) operating at 80 kV and equipped with a CCD camera (VELETA; Olympus Soft 
Imaging Solutions GmbH, Germany).
Quantification of mtDNA. Total genomic DNA was extracted and purified from cells, and diluted to 5 ng/
μL. To quantify the amount of mtDNA per nuclear DNA, quantitative real-time polymerase chain reaction (qPCR) 
was performed using FastStart Essential DNA Green Master (Roche). Quantification of relative copy number dif-
ferences was performed based on the difference in the threshold amplification between mtDNA and nuclear DNA 
[ΔΔC(t) method]. We used the following sets of primers for mtDNA: TK702 (5′-cctatcacccttgccatcat, forward) 
and TK703 (5′-gaggctgttgcttgtgtgac, reverse); and for nuclear DNA: TK704 (5′-atggaaagcctgccatcatg, forward) 
and TK705 (5′-tccttgttgttcagcatcac, reverse).
Cytochemical analysis of cytochrome c oxidase (COX) activity. COX staining was performed as pre-
viously described41 with slight modifications. MEFs plated on 18-mm coverslips were fixed with 2% paraformal-
dehyde in PBS for 15 min and washed twice with PBS for 5 min each. To visualize COX activity, cells were stained 
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with 100 mM phosphate buffer (pH 7.4) containing 0.6 mg/mL 3′,3′-diaminobenzidine, 0.3 mg/mL cytochrome 
c, and 45 mg/mL sucrose at 37 °C for 2 h. Cells were then washed twice with 0.1 M Tris-HCl buffer (pH 8.0) for 
5 min each and analyzed by microscopy.
Statistical analysis. An analysis of variance test (GraphPad QuickCalcs) was used for the statistical analy-
ses. A P-value of less than 0.05 was considered statistically significant.
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